This study aims to confirm the factor structure of the Menopause-Specific Quality of Life ( MENQOL ) questionnaire by using confirmatory factor analysis ( CFA ) and to determine whether improvements in menopause-specific health-related quality of life ( HRQOL ) observed with bazedoxifene ( BZA ) / conjugated estrogens ( CE ) relative to placebo are clinically meaningful .